ACE and systemic lupus erythematosus: The most frequently used SLE and LN treatments were corticosteroids (47.2–60.0%), antimalarials (40.6–51.0%), and angiotensin‐converting enzyme (ACE) inhibitors/angiotensin receptor blockers (ARBs) (40.6–44.5%; Table 3) with the proportion of patients with any treatment use being highest during the first 6-month interval with the exception of ACE inhibitors/ARBs (Table 3).